AP7

WikiDoc Resources for AP7
Articles
Most recent articles on AP7 Most cited articles on AP7 Review articles on AP7 Articles on AP7 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on AP7 Images of AP7 Photos of AP7 Podcasts & MP3s on AP7 Videos on AP7
Evidence Based Medicine
Cochrane Collaboration on AP7 Bandolier on AP7 TRIP on AP7
Clinical Trials
Ongoing Trials on AP7 at Clinical Trials.gov Trial results on AP7 Clinical Trials on AP7 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on AP7 NICE Guidance on AP7 NHS PRODIGY Guidance FDA on AP7 CDC on AP7
Books
Books on AP7
News
AP7 in the news Be alerted to news on AP7 News trends on AP7
Commentary
Blogs on AP7
Definitions
Definitions of AP7
Patient Resources / Community
Patient resources on AP7 Discussion groups on AP7 Patient Handouts on AP7 Directions to Hospitals Treating AP7 Risk calculators and risk factors for AP7
Healthcare Provider Resources
Symptoms of AP7 Causes & Risk Factors for AP7 Diagnostic studies for AP7 Treatment of AP7
Continuing Medical Education (CME)
CME Programs on AP7
International
AP7 en Espanol AP7 en Francais
Business
AP7 in the Marketplace Patents on AP7
Experimental / Informatics
List of terms related to AP7

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

AP7 is a selective NMDA receptor (NMDAR) antagonist that competitively inhibits the active site of NMDAR. Its chemical name is 2-amino-7-phosphonoheptanoic acid.

Template:WikiDoc Sources